Mechanistically, SFRP2, a key gene in Risk<sup>H</sup>, promoted CRC glycolysis and metastasis via enolase 2 (ENO2) activation through the TCF4/β-catenin axis. Here, ENO2 is linked to colorectal carcinoma.